Comparison Between Two Different Dosages of Remifentanil During Colonoscopy
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized double-blind trial is to define the correct dosage of
Remifentanil during operative and diagnostic endoscopic procedures. In particular we want to
analyze if the administration of Remifentanil by PCSA (Patient Controlled Sedation and
Analgesia) is a good method during colonoscopy, evaluating pain control, discharge time and
side effects.
90 patients undergoing colonoscopy will be enrolled.